¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"copper sulfate method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • fast gradient recalled echo method
    °í¼Ó±â¿ï±âȸº¹¿¡ÄÚ¹ý
  • fluoroimmunometric method
    Çü±¤¸é¿ªÃøÁ¤¹ý
  • gasometric method
    °¡½ºÁ¤·®¹ý
  • gradient method
    °è´Ü°Ë»ç¹ý
  • graphic method
    ±×·¡ÇÁ¹ý, ¼±µµ¹ý
  • gravimetric method
    Áß·®¹ý
  • high flow method
    °íÀ¯·®¹ý
  • homozygous typing method
    µ¿Á¾Á¢ÇÕÇüº°ÆÇº°¹ý
  • hanging drop method
    ÇöÀû¹ý
  • introspective method
    ³»¼º¹ý
  • isodose shift method
    µî¼±·®À̵¿¹ý
  • immersion method
    ¼öħ¹ý
  • immunodiagnostic method
    ¸é¿ªÁø´Ü¹ý
  • impression method
    Àλó¹ý
  • indicator dilution method
    Áö½Ã¾àÈñ¼®¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • exact method
    Á÷Á¢È®·ü¹ý
  • exclusion method
    ¹èÁ¦¹æ¹ý
  • expansion method
    ÆØÃ¢¹æ¹ý
  • fast gradient recalled echo method
    °í¼Ó±â¿ï±âȸº¹¿¡ÄÚ¹ý
  • fluoroimmunometric method
    Çü±¤¸é¿ª°èÃø¹ý
  • gasometric method
    °¡½ºÁ¤·®¹ý
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
  • graphic method
    ±×·¡ÇÁ¹ý, ¼±µµ¹ý
  • gravimetric method
    Áß·®¹ý
  • hanging drop method
    ÇöÀû¹ý
  • high flow method
    °íÀ¯·®¹ý
  • homozygous typing method
    µ¿ÇüÁ¢ÇÕ¼ºÇüº°ÆÇº°¹ý
  • immersion method
    ¼öħ¹ý
  • immunodiagnostic method
    ¸é¿ªÁø´Ü¹ý
  • impression method
    Àλó¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • gravimetric method
    Áß·®¹ý(ñìÕáÛö).
  • hanging drop method
    ÇöÀû¹ý(úØîÙÛö).
  • hemiglobincyanide <= cyanmethemoglobin> method
    ½Ã¾ÈÇì¹Ì±Û·Îºó¹ý<½Ã¾È¸ÞÆ®Çì¸ð±Û·Îºó¹ý>
  • high flow method
    °íÀ¯·®¹ý(ÍÔêüåÖÛö).
  • homozygous typing method
    µ¿ÇüÁ¢ÇÕ¼º Çüº°ÆÇº°¹ý
  • hypobromite method
    ÇÏÀÌÆ÷ºê·Ò»ê¿°¹ý.
  • illumination method
    Á¶¸í¹ý(Ì¡ËÎËÑ).
  • immersion method
    ¼öħ¹ü (â©öÙÛö)
  • immunodiagnostic method
    ¸é¿ªÁø´Ü(¹æ)¹ý
  • impression method
    Àλó¹ý(ìÔßÚÛö).
  • incision method
    Àý°³¹ý(ü°³¹ý).
  • indicator dilution method
    Áö½Ã¾àÈñ¼®¹ý.
  • indirect direct method
    °£Á¢Á÷Á¢¹ý(ÊàïÈòÁ ïÈÛö).
  • infrared absorption method
    È£±â°¡½ººÐ¼®½Ã Àû¿Ü¼± Èí¼ö¹ý
  • injection cast corrosion method
    Ç÷°üÁÖÇüÀÛÁ¦¹ý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bidiazotized benzidine method
    ¹ÙÀ̵ð¾ÆÁ¶È­º¥Áöµò¹ý
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý(¡­ËþïÒÛö).
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý(ÊÙË§ËøËÑ).
  • bisecting method
    À̵îºÐ¸é¹ý(¡­ÝÂØüÛö).
  • biuret method
    ºä·¿(¹æ)¹ý
  • bleaching method of discolored teeth
    º¯»öġǥ¹é¹ý(ܨßäöÍø÷ÛÜÛö).
  • bolus-tracking method
    µ¢¾î¸® ÃßÀû ¹æ¹ý
  • candle jar method
    Ä­µéÀÚ¾Æ(¹è¾ç)¹ý.
  • candle jar method
    Ä­µéÀÚ¾Æ(¹è¾ç)¹ý.
  • capillary tube method
    ¸ð¼¼½ÃÇè°ü¹ý
  • catharsis method
    °¨Á¤Á¤È­ ¹æ¹ý
  • cava pocket method
    ´ëÁ¤¸ÆÆ÷ÄϹý(ÓÞð¡Øæ¡­Ûö).
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • checkerboard method
    ¹ÙµÏÆÇ(¹æ)¹ý
  • closed dressing method
    Æó¼âºØ´ë¹ý (¡­ºØ´ë¹ý).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Maxam-Gilbert method
    ¸·»ï-±æ¹öÆ®¹ý(Ûö)
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • Merrifield method
    ¸Þ¸®Çʵå¹ý(Ûö)
  • method of continuous variation
    ¿¬¼Óº¯È­¹ý(Ö§áÙܨûùÛö)
  • method of optimal proportions
    ÀûÁ¤ºÎºÐ¹ý(îêïÒÝ»ÝÂÛö)
  • Ouchterlony method
    ¿ìÅ©ÅÚ·Î´Ï ¹æ¹ý(Û°Ûö)
  • overlap method
    Áßø¹ý(ñìôáÛö)
  • paraffin method
    ÆÄ¶óÇÉ ¹ý(Ûö)
  • Park and Johnson method
    ÆÄÅ© Á¸½¼ ¹ý(Ûö)
  • pattern method
    ÆäÅϹý(Ûö)
  • PER method
    PER¹ý(Ûö)
  • pH jump method
    pH ±Þº¯¹ý(ÐáܨÛö)
  • phosphite-triester method
    Æ÷½ºÆÄÀÌÆ®-»ï(ß²)¿¡½ºÅ͹ý(Ûö)
  • plaque reduction method
    ÇöóÅ© °¨¼Ò¹ý(Êõá´Ûö)
  • plus-minus method
    °¡°¨¹ý(Ê¥ÊõÛö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CSP carotid sinus pressure; cavum septi pellucidi; cell surface protein; cerebrospinal protein; Chartere...
CSPG chondroitin sulfate proteoglycan
DAS dead air space; Death Anxiety Scale; delayed anovulatory syndrome; dextroamphetamine sulfate; digita...
DDS damaged disc syndrome; dendrodendritic synaptosome; dental distress syndrome; depressed DNA synthesi...
DHEAS dehydroepiandrosterone sulfate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MHPG-SO4 3-methoxy-4-hydroxy-phenylethylene glycol sulfate
S 3-sulfate
SDS 6%-sodium dodecyl sulfate
AS Ammonium sulfate
CS Cholesterol sulfate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Leifson Method
    ·¹ÀÌÇÁ¼ø ¹ý
    ¼¼±ÕÀÇ Æí¸ð ¿°»ö¹ýÀÇ ÀÏÁ¾.
  • Lustgarten's method
    ·ç½ºÆ®°¡¸£ÅÙ¹ý
    ¸Åµ¶ ±ÕÀ» ¿°»öÇÏ´Â ¹ý.
  • method
    ¹æ¹ý, ¹ý, ½Ä, ¹æ½Ä
    ¾î¶² ÇàÀ§³ª ¼ö¼úÀ» ½ÃÇàÇÏ´Â ¹æ¹ý. óġ ¶Ç´Â ¼ö±â.
  • microfilm method
    ¹Ú¸·¹ý
  • mouth-to-mouth method
    Á¢±¸¹ý
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nielsen's method
    ´Ò¼¾ Àΰø È£Èí¹ý
    ȯÀÚ¸¦ ¿ÞÂÊÀ¸·Î ¸ð·Î ´©À̰í, ¸Ó¸®¿¡ º£°³¸¦ ¹ÞÄ£ ´ÙÀ½, ¿ÞÂÊ ÆÈ´Ù¸®¸¦ ¾à°£ ±ÁÈù »óÅ¿¡¼­, ÈäºÎÀÇ ¾çÂÊÀ¸·ÎºÎÅÍ ¾Ð¹ÚÀ» °¡ÇØ È£±â¸¦ ÀÏÀ¸Å°°í, »ó¿ÏÀ» ¾ÕµÚ·Î ¿òÁ÷¿©¼­ Èí±â¸¦ ÀÏÀ¸Å°´Â ¹ý.
  • Nirenstein-Schiff's method
    ´Ï·»½ÃŸÀÎ ½ÃÇÁ ¹ý
    Æé½ÅÀÇ Á¤·®¹ýÀ¸·Î, ´Ü¹éÁúÀ» ÀÏÁ¤ ¿Âµµ¿Í ÀÏÁ¤ ½Ã°£ ³»¿¡ ¼ÒÈ­ÇÏ´Â ÈûÀ¸·Î½á ¿ª°¡¸¦ ÆÇÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • Nissl's method
    ´Ï½½ ¿°»ö¹ý
    ½Å°æ ¼¼Æ÷ °ú¸³ÀÇ ¿°»ö¹ýÀ¸·Î, 90% ¾ËÄڿ÷ΠÁ¶Á÷À» °íÁ¤Çϰí, ´Ï½½ ¿°»ö¾×À¸·Î ¿°»öÇÑ ÈÄ 10% ¾Æ´Ò¸° ¾ËÄڿ÷ΠŻ»öÇÏ´Â ¹ý.
  • one probe method
    ´ÜÀÏ Å½ÃËÀÚ ¹æ½Ä
  • palladiometric method
    ÆÈ¶óµã ¹ý
  • paralleling method
    ÆòÇà¹ý
  • plate dilution method
    ÆòÆÇ Èñ¼®¹ý
  • Plummer's method
    Ç÷¯¸Ó¹ý
    °©»ó¼±Á¾ÀÇ ÃËÁø¹ýÀ¸·Î, Èä°ñ À¯µ¹±ÙÀÇ ÈĹæÀ¸·Î ¿Þ¼ÕÀ» ³ÖµÇ ¾öÁö¼Õ°¡¶ôÀ» ¾ÕÀ¸·Î ÇÏ¿© ¿ì¿±À» ¾Ð¹ÚÇϰí, ¿À¸¥¼ÕÀº ¿Þ¼Õ ÂÊÀ» ÇâÇØ ¾Ð¹ÚÇÏ´Â ¹ý.
  • powder-liquid method
    ºÐ, ¾×¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
polysaccharide sulfate esters Sulfate esters of polysaccharides often found in cell walls.
(05 Mar 2000)
cupric sulfate CuSo4-5H2O;it is highly poisonous to algae, is a prompt and active emetic, and is used as an irritant, astringent, and fungicide.
Synonym: copper sulfate, copper sulphate.
(05 Mar 2000)
potassium sulfate K2SO4;an obsolete laxative.
(05 Mar 2000)
proflavine (hemi)sulfate The neutral sulfate of 3,6-diaminoacridine; a compound closely allied to acriflavine, having similar antiseptic properties.
(05 Mar 2000)
heparan sulfate <chemical> Heparitin, sulfate. A glycosaminoglycan occurring in the liver, aorta, and lung. It has a structure similar to heparin, but there are more n-acetyl groups and fewer o- and n-sulfate groups. It is an accumulation product in several mucopolysaccharidoses.
Chemical name: Heparitin, sulfate
(12 Dec 1998)
heparan-sulfate 2-sulfotransferase <enzyme> An o-sulfotransferase that catalyses transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to l-iduronic acid at position 2 of heparan sulfate; genbank d88811
Registry number: EC 2.8.2.-
Synonym: hs2st enzyme
(26 Jun 1999)
heparan sulfate D-glucosaminyl 3-O-sulfotransferase <enzyme> Involved in biosynthesis of heparan sulfate proteoglycans
Registry number: EC 2.8.2.-
Synonym: hsg 3-o-sulfotransferase
(26 Jun 1999)
heparan sulfate-N-deacetylase-N-sulfotransferase <enzyme> Catalyses both the n-deacetylation and the n-sulfation reactions that begin modification of heparan sulfate's oligosaccharide backbone
Registry number: EC 2.8.2.-
Synonym: hs-ndac-nst
(26 Jun 1999)
heparan sulfate proteoglycan Ubiquitous macromolecules associated with the cell surface and extracellular matrix of a wide range of cells of vertebrate and invertebrate tissues. They are essential cofactors in cell-matrix adhesion processes, in cell-cell recognition systems, and in receptor-growth factor interactions.
(12 Dec 1998)
heparan sulfate sulfatase <enzyme> Probable defect in sanfilippo a syndrome
Registry number: EC 3.1.6.-
Synonym: heparan sulphatase
(26 Jun 1999)
heparitin sulfate <chemical> Heparitin, sulfate. A glycosaminoglycan occurring in the liver, aorta, and lung. It has a structure similar to heparin, but there are more n-acetyl groups and fewer o- and n-sulfate groups. It is an accumulation product in several mucopolysaccharidoses.
Chemical name: Heparitin, sulfate
(12 Dec 1998)
heparosan N-sulfate D-glucuronosyl 5-epimerase <enzyme> Converts d-glucuronic acid to l-iduronic at the polymer level during synthesis of heparin
Registry number: EC 5.1.3.17
Synonym: uronosyl c-5 epimerase, d-glucuronyl c-5 epimerase
(26 Jun 1999)
protamine sulfate A purified mixture of simple protein principles from the sperm or testes of suitable species of fish; it is a heparin antagonist used in certain haemorrhagic states associated with increased amounts of heparin-like substances in the circulation and for the treatment of heparin overdosage.
(05 Mar 2000)
pyribenzyl methyl sulfate 2-(hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate benzylate;an anticholinergic agent.
Synonym: pyribenzyl methyl sulfate.
(05 Mar 2000)
hydroxychloroquine sulfate A quinoline derivative; an antimalarial agent whose actions and uses resemble those of chloroquine phosphate; also used in the treatment of lupus erythematosus and rheumatoid arthritis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á